|
|
8023 Vantage Dr
8023 Vantage Dr
TX
United States
210-255-6892
|
|
Private
|
KCI’s innovative therapies make a difference in patients' lives every day. KCI’s therapies can be found helping patients recovering in all care settings. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our products are backed by a worldwide network of service and clinical support. As we approach our 30-year anniversary, KCI has emerged as a global medical technology leader with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products which can help significantly improve clinical outcomes while helping to reduce the overall cost of patient care.
Innovation
KCI was founded on a spirit of innovation. KCI introduced to the market innovations that today are considered standard of care because they were designed for specific patient conditions.
KCI got its start in 1976, focused on helping to treat patients and to prevent complications related to patient immobility. Dr. Jim Leininger, an emergency room physician, realized that patients would often survive serious physical trauma, only to develop life-threatening complications as the result of their immobility. He knew that if he could just keep the patients mobilized, they would survive. Early success led to the development or acquisition of our patented line of advanced therapeutic specialty beds, surfaces and related devices including the RotoProne® Therapy System, AtmosAir® 9000AR Mattress Replacement System and the First Step® Advantage therapeutic overlay. The KCI Continuum of Care also addresses the therapeutic and risk management concerns of caring for bariatric patients.
In 1995, KCI launched its largest innovation yet, the V.A.C.® Therapy System, which has been clinically proven to help promote wound healing while helping to decrease length of stay and incidence of complications. Part of the innovative system includes the use of V.A.C.® GranuFoam® and V.A.C.® WhiteFoam Dressings, which are critical to deliver effective Negative Pressure Wound Therapy (NPWT). Each dressing is engineered for specific wound applications to provide outcomes clinicians can trust. The V.A.C.® Therapy System™ is backed by one of the most substantial clinical evidence bases in wound care. In 2005, KCI launched V.A.C.® GranuFoam® Silver™ Dressings further building on its innovative heritage.
|
|
http://www.kci1.com
|
|
|
|
|
|
|
|
|
|
PulseSC™ System Product Literature
The Pulse SCTM by KCI (System 2600) offers a clinically effective method for aiding in increased venous blood flow and helping to prevent clot formation. Used before, during and after surgery, the Pulse SC aides in reducing the threat of DVT and PE.
read more...
|
|
|
|
|
|
|